MICHAEL W. ROGERS

Insider Reports History

Location
Boston, MA
Signature
/s / Carolyn Rucci, attorney-in-fact for Michael W. Rogers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MICHAEL W. ROGERS:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. Director Common Stock 161,729 $423,729 $2.62 10 Jun 2025 Direct
Aravive, Inc. Director Stock Option (Right to Buy) 97,063 23 Sep 2022 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 53,600 10 Jun 2025 Direct

Insider Reports Filed by MICHAEL W. ROGERS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 10 Jun 2025 2 $0 4 Director 11 Jun 2025, 17:14
AKBA Akebia Therapeutics, Inc. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 16:19
AKBA Akebia Therapeutics, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 16:08
/report/000143774922023060-rogers-michael-w-2022-09-23 Aravive, Inc. 23 Sep 2022 1 $0 4 Director 26 Sep 2022, 16:07
AKBA Akebia Therapeutics, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 16:58
/report/000143774921022011-rogers-michael-w-2021-09-10 Aravive, Inc. 10 Sep 2021 1 $0 4 Director 13 Sep 2021, 16:06
AKBA Akebia Therapeutics, Inc. 02 Jun 2021 2 $0 4 Director 03 Jun 2021, 17:27